⌘K

Login Start Free

Home/Filings/4/0001209191-22-018488

4//SEC Filing

Macfarlane K. Angela 4

Accession 0001209191-22-018488

CIK 0001574094other

View on SEC.gov Company Profile

Filed

Mar 13, 8:00 PM ET

Accepted

Mar 14, 4:45 PM ET

Size

5.3 KB

Accession

0001209191-22-018488

Insider Transaction Report

Form 4

Period: 2022-03-10

RenovoRx, Inc.RNXT

Macfarlane K. Angela

Director

Transactions

Award
Stock option (right to buy)
2022-03-10−4,582→ 4,582 total
Exercise: $3.17Exp: 2032-03-10→ Common Stock (4,582 underlying)

Footnotes (1)

[F1]The shares subject to the option vest in twelve equal monthly installments beginning on November 1, 2021.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

RenovoRx, Inc.

CIK 0001574094

Entity typeother

Related Parties

1

filerCIK 0001865182

Filing Metadata

Form type: 4
Filed: Mar 13, 8:00 PM ET
Accepted: Mar 14, 4:45 PM ET
Size: 5.3 KB

View on SEC.gov